Biotechnology Ignition Grant vs BIPP, BioNEST and Startup India Seed Fund: Which Should You Choose?

Which biotech funding scheme should you choose?

Choose the Biotechnology Ignition Grant (BIG) if you are a startup, LLP or incubatee under three years old with an early idea that needs up to Rs 50 lakh to reach proof of concept; choose BIPP if your company is more mature and past three years; choose BioNEST if you need incubation space rather than a grant; and choose the Startup India Seed Fund Scheme if your idea is not biotech at all. This article compares BIG against the three alternatives its own parent guide names. For BIG's full eligibility and process, read the parent guide on the Biotechnology Ignition Grant; the one-line reminder is that BIG is grant-in-aid: BIRAC takes no equity and there is no repayment.

The decision at a glance

BIG vs BIPP: it comes down to company age

BIG and BIPP are both BIRAC schemes, which is why they are most often confused. The deciding factor is maturity. A start-up applying under BIG must not be more than three years old from the date the call was launched, and BIG funds the leap from a laboratory idea to a demonstrable proof of concept. BIPP (the Biotechnology Industry Partnership Programme) is built for more mature entities working on high-risk, future technologies. If your company has crossed three years, you are outside BIG and BIPP is the natural next door; if you are pre-proof-of-concept and young, BIG fits.

BIG vs BioNEST: grant versus space

BIG gives you money against milestones. BioNEST does not fund your company directly, it supports bio-incubators that in turn host early-stage biotech ventures. If your blocker is that you have no laboratory, BioNEST-supported incubators (and BIG Partners such as C-CAMP, IKP Knowledge Park and Venture Center) give you the bench space and mentoring. In fact the two are complementary rather than exclusive: an incubatee physically hosted at a bio-incubator can apply to BIG for the grant, using the incubation arrangement to satisfy BIG's laboratory-access condition.

BIG vs Startup India Seed Fund: is your idea biotech?

The cleanest fork. BIG is biotech-only, awarded by BIRAC under the Department of Biotechnology. The Startup India Seed Fund Scheme is run by DPIIT and is sector-agnostic, disbursed through recognised incubators to startups of any domain. If your idea is not biotechnology, BIG will not apply and the Seed Fund is the route. If it is biotech, BIG's specialist evaluation and partner network are the stronger fit.

Can you hold more than one?

• BIG and BioNEST together: effectively yes: BioNEST is infrastructure support to the incubator, and being incubated there helps you meet BIG's eligibility, so an incubatee can hold both relationships at once.
• BIG and BIPP: these serve different maturity stages and are applied for separately; you would not typically run both for the same early-stage project, and BIPP suits you only once you have outgrown BIG's three-year window.
• BIG and the Seed Fund: they target different sectors and are administered by different bodies (BIRAC vs DPIIT). Applicants should read each scheme's own guidelines on stacking public grants for the same expenditure, since a single cost item generally cannot be funded twice.

Which should you apply for first?

Sequence by stage. If you are a young biotech venture pre-proof-of-concept, apply to BIG first. It is designed exactly for that gap. Secure incubation via a BioNEST-supported incubator in parallel if you lack a laboratory, because that also unlocks BIG eligibility. Move to BIPP only once the company matures past three years. Use the Seed Fund if the idea turns out to be outside biotech. Verify the current terms of each scheme on its official page before deciding, as ceilings and windows are revised from time to time.

For BIG specifically, check the open call at birac.nic.in/cfp.php and register early on www.birac.nic.in; there is no fee, and BIRAC appoints no agents.